enVVeno Medical Corp
NVNO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001661053
In the last 90 days, enVVeno Medical Corp insiders filed 0 open-market purchases and 1 sale; 17 institutions reported holding it in 13F filings for Q2 2026, worth $953.6K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in enVVeno Medical Corp as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- 0 vs. Q1 2026
- Shares held
- 88.7K
- −11.8K (−11.7%) vs. Q1 2026
- Total value
- $953.6K
- −$64.7K (−6.3%) vs. Q1 2026
- New holders
- 3
- 0 more added
- Sold out
- 3
- 6 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NVNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $953.6K |
| Q1 2026 | 17 | $1.02M |
| Q4 2025 | 36 | $2.10M |
| Q3 2025 | 37 | $5.60M |
| Q2 2025 | 37 | $20.3M |
| Q1 2025 | 31 | $9.61M |
| Q4 2024 | 35 | $12.9M |
| Q3 2024 | 36 | $17.5M |
| Q2 2024 | 26 | $19.8M |
| Q1 2024 | 32 | $20.9M |
| Q4 2023 | 30 | $26.9M |
| Q3 2023 | 24 | $10.4M |
| Q2 2023 | 23 | $5.90M |
| Q1 2023 | 18 | $8.50M |
| Q4 2022 | 22 | $8.46M |
| Q3 2022 | 22 | $13.7M |
| Q2 2022 | 21 | $8.11M |
| Q1 2022 | 21 | $13.0M |
| Q4 2021 | 24 | $18.9M |
| Q3 2021 | 1 | $127.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding enVVeno Medical Corp; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Kingdon Capital Management, L.L.C. | 36,166 | $387.3K | 0.05% | 00.0% | Unchanged |
| CM Management, LLC | 35,714 | $382.5K | 0.24% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 6,287 | $67.4K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 5,208 | $59.1K | 0.00% | −10.0% | Reduced |
| Vanguard Fiduciary Trust Co | 2,184 | $23.4K | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 1,525 | $16.3K | 0.00% | −64−4.0% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 539 | $5.77K | 0.00% | +539 | New |
| BlackRock, Inc. | 414 | $4.43K | 0.00% | −1,426−77.5% | Reduced |
| Tower Research Capital LLC (TRC) | 331 | $3.54K | 0.00% | −211−38.9% | Reduced |
| Wells Fargo & Company | 114 | $1.22K | 0.00% | 00.0% | Unchanged |
| Allied Private Wealth LLC | 88 | $978 | 0.00% | +88 | New |
| Vanguard Global Advisers, LLC | 77 | $825 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 59 | $632 | 0.00% | −17−22.4% | Reduced |
| Advisor Group Holdings, Inc. | 7 | $74 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2 | $21 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $21 | 0.00% | +2 | New |
| UBS Group AG | 1 | $11 | 0.00% | −242−99.6% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −10,455−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |